Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection

Journal of Immunology

Volumn 184, Issue 3, 2010, Pages 1445-1454

  Goodyear, Andrew ^a   Jones, Abby ^a   Troyer, Ryan ^a   Bielefeldt Ohmann, Helle ^a,b   Dow, Steven ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; GAMMA INTERFERON; INTERLEUKIN 12; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT GAMMA INTERFERON; CCL2 PROTEIN, MOUSE; CCR2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURKHOLDERIA INFECTION; BURKHOLDERIA MALLEI; C57BL 6 MOUSE; CELL MIGRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE PREDISPOSITION; IMMUNOREGULATION; LUNG; MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE; ANIMAL; BACTERIAL PNEUMONIA; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BURKHOLDERIA INFECTIONS; BURKHOLDERIA MALLEI; CELL MOVEMENT; CHEMOKINE CCL2; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, CELLULAR; INTERFERON-GAMMA; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; NEUTROPHIL INFILTRATION; PNEUMONIA, BACTERIAL; RECEPTORS, CCR2;

EID: 77949315237     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900411     Document Type: Article

References (50)

1. Dvorak, G. D., and A. R. Spickler. 2008. Glanders. J. Am. Vet. Med. Assoc. 233: 570-577.
2. Whitlock, G. C., D. M. Estes, and A. G. Torres. 2007. Glanders: off to the races with Burkholderia mallei. FEMS Microbiol. Lett. 277: 115-122.
3. Leelarasamee, A. 2004. Recent development in melioidosis. Curr. Opin. Infect. Dis. 17: 131-136.
4. Wiersinga, W. J., T. van der Poll, N. J. White, N. P. Day, and S. J. Peacock. 2006. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 4: 272-282.
5. Peacock, S. J. 2006. Melioidosis. Curr. Opin. Infect. Dis. 19: 421-428.
6. Gilad, J., I. Harary, T. Dushnitsky, D. Schwartz, and Y. Amsalem. 2007. Burkholderia mallei and Burkholderia pseudomallei as bioterrorism agents: national aspects of emergency preparedness. Isr. Med. Assoc. J. 9: 499-503.
7. Santanirand, P., V. S. Harley, D. A. Dance, B. S. Drasar, and G. J. Bancroft. 1999. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect. Immun. 67: 3593-3600.
8. Barnes, J. L., N. L. Williams, and N. Ketheesan. 2008. Susceptibility to Burkholderia pseudomallei is associated with host immune responses involving tumor necrosis factor receptor-1 (TNFR1) and TNF receptor-2 (TNFR2). FEMS Immunol. Med. Microbiol. 52: 379-388.
9. Easton, A., A. Haque, K. Chu, R. Lukaszewski, and G. J. Bancroft. 2007. A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. J. Infect. Dis. 195: 99-107.
10. Breitbach, K., S. Klocke, T. Tschernig, N. van Rooijen, U. Baumann, and I. Steinmetz. 2006. Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect. Immun. 74: 6300-6309.
11. Lever, M. S., M. Nelson, P. I. Ireland, A. J. Stagg, R. J. Beedham, G. A. Hall, G. Knight, and R. W. Titball. 2003. Experimental aerogenic Burkholderia mallei (glanders) infection in the BALB/c mouse. J. Med. Microbiol. 52: 1109-1115.
12. Serbina, N. V., T. Jia, T. M. Hohl, and E. G. Pamer. 2008. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26: 421-452.
13. Serbina, N. V., and E. G. Pamer. 2006. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7: 311-317.
14. Serbina, N. V., W. Kuziel, R. Flavell, S. Akira, B. Rollins, and E. G. Pamer. 2003. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity 19: 891-901.
15. Kipnis, A., R. J. Basaraba, I. M. Orme, and A. M. Cooper. 2003. Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis. Immunology 109: 547-551. (Pubitemid 36930170)
16. Peters, W., H. M. Scott, H. F. Chambers, J. L. Flynn, I. F. Charo, and J. D. Ernst. 2001. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 98: 7958-7963.
17. Ulrich, R. L., K. Amemiya, D. M. Waag, C. J. Roy, and D. DeShazer. 2005. Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice. Vaccine 23: 1986-1992.
18. Romero, C. M., D. DeShazer, T. Feldblyum, J. Ravel, D. Woods, H. S. Kim, Y. Yu, C. M. Ronning, and W. C. Nierman. 2006. Genome sequence alterations detected upon passage of Burkholderia mallei ATCC 23344 in culture and in mammalian hosts. BMC Genomics 7: 228.
19. Bosio, C. M., A. W. Goodyear, and S. W. Dow. 2005. Early interaction of Yersinia pestis with APCs in the lung. J. Immunol. 175: 6750-6756.
20. Fisher, J. H., J. Larson, C. Cool, and S. W. Dow. 2002. Lymphocyte activation in the lungs of SP-D null mice. Am. J. Respir. Cell Mol. Biol. 27: 24-33.
21. Mathes, M., M. Jordan, and S. Dow. 2006. Evaluation of liposomal clodronate in experimental spontaneous autoimmune hemolytic anemia in dogs. Exp. Hematol. 34: 1393-1402.
22. Mastroeni, P., J. A. Harrison, J. H. Robinson, S. Clare, S. Khan, D. J. Maskell, G. Dougan, and C. E. Hormaeche. 1998. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect. Immun. 66: 4767-4776.
23. Rollins, B. J. 1996. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol. Med. Today 2: 198-204.
24. Rollins, B. J. 1997. Chemokines. Blood 90: 909-928.
25. Gu, L., S. C. Tseng, and B. J. Rollins. 1999. Monocyte chemoattractant protein- 1. Chem. Immunol. 72: 7-29.
26. Gerard, C., and B. J. Rollins. 2001. Chemokines and disease. Nat. Immunol. 2: 108-115.
27. Jia, T., N. V. Serbina, K. Brandl, M. X. Zhong, I. M. Leiner, I. F. Charo, and E. G. Pamer. 2008. Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. J. Immunol. 180: 6846-6853.
28. Tsou, C. L., W. Peters, Y. Si, S. Slaymaker, A. M. Aslanian, S. P. Weisberg, M. Mack, and I. F. Charo. 2007. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117: 902-909.
29. Rowland, C. A., G. Lertmemongkolchai, A. Bancroft, A. Haque, M. S. Lever, K. F. Griffin, M. C. Jackson, M. Nelson, A. O'Garra, R. Grencis, et al. 2006. Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei. Infect. Immun. 74: 5333-5340.
30. Haque,A., A. Easton,D. Smith,A.O'Garra,N.Van Rooijen,G. Lertmemongkolchai, R. W. Titball, and G. J. Bancroft. 2006. Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J. Infect. Dis. 193: 370-379.
31. Randolph, G. J., G. Sanchez-Schmitz, and V. Angeli. 2005. Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances. Springer Semin. Immunopathol. 26: 273-287.
32. Jakubzick, C., F. Tacke, J. Llodra, N. van Rooijen, and G. J. Randolph. 2006. Modulation of dendritic cell trafficking to and from the airways. J. Immunol. 176: 3578-3584. (Pubitemid 43364005)
33. van Rooijen, N., and E. van Kesteren-Hendrikx. 2003. "In vivo" depletion of macrophages by liposome-mediated "suicide". Methods Enzymol. 373: 3-16.
34. Serbina, N. V., T. P. Salazar-Mather, C. A. Biron, W. A. Kuziel, and E. G. Pamer. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19: 59-70.
35. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-823.
36. Scott, H. M., and J. L. Flynn. 2002. Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression. Infect. Immun. 70: 5946-5954.
37. Peters, W., M. Dupuis, and I. F. Charo. 2000. A mechanism for the impaired IFN-gamma production in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate and adaptive immune responses. J. Immunol. 165: 7072-7077. (Pubitemid 32001181)
38. Winter, C., W. Herbold, R. Maus, F. Länger, D. E. Briles, J. C. Paton, T. Welte, and U. A. Maus. 2009. Important role for CC chemokine ligand 2-dependent lung mononuclear phagocyte recruitment to inhibit sepsis in mice infected with Streptococcus pneumoniae. J. Immunol. 182: 4931-4937.
39. Sato, N., S. K. Ahuja, M. Quinones, V. Kostecki, R. L. Reddick, P. C. Melby, W. A. Kuziel, and S. S. Ahuja. 2000. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)- inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 192: 205-218.
40. H2 polarization by the chemokine monocyte chemoattractant protein- 1. Nature 404: 407-411.
41. Robben, P. M., M. LaRegina, W. A. Kuziel, and L. D. Sibley. 2005. Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis. J. Exp. Med. 201: 1761-1769.
42. Mordue, D. G., and L. D. Sibley. 2003. A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis. J. Leukoc. Biol. 74: 1015-1025.
43. Traynor, T. R., A. C. Herring, M. E. Dorf, W. A. Kuziel, G. B. Toews, and G. B. Huffnagle. 2002. Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J. Immunol. 168: 4659-4666.
44. Traynor, T. R., W. A. Kuziel, G. B. Toews, and G. B. Huffnagle. 2000. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164: 2021-2027.
45. Randolph, G. J., S. Beaulieu, S. Lebecque, R. M. Steinman, and W. A. Muller. 1998. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282: 480-483.
46. Goodyear, A., L. Kellihan, H. Bielefeldt-Ohmann, R. Troyer, K. Propst, and S. Dow. 2009. Protection from pneumonic infection with burkholderia species by inhalational immunotherapy. Infect. Immun. 77: 1579-1588.
47. Dow, S. W., L. G. Fradkin, D. H. Liggitt, A. P. Willson, T. D. Heath, and T. A. Potter. 1999. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J. Immunol. 163: 1552-1561.
48. Zisman, D. A., S. L. Kunkel, R. M. Strieter, W. C. Tsai, K. Bucknell, J. Wilkowski, and T. J. Standiford. 1997. MCP-1 protects mice in lethal endotoxemia. J. Clin. Invest. 99: 2832-2836.
49. Scott, M. G., E. Dullaghan, N. Mookherjee, N. Glavas, M. Waldbrook, A. Thompson, A. Wang, K. Lee, S. Doria, P. Hamill, et al. 2007. An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 25: 465-472.
50. Nakano, Y., T. Kasahara, N. Mukaida, Y. C. Ko, M. Nakano, and K. Matsushima. 1994. Protection against lethal bacterial infection in mice by monocytechemotactic and -activating factor. Infect. Immun. 62: 377-383.